SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-131744
Filing Date
2014-04-04
Accepted
2014-04-04 16:10:24
Documents
5
Period of Report
2014-04-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d706613d8k.htm 8-K 14328
2 EX-10.1 d706613dex101.htm EX-10.1 63930
3 EX-10.2 d706613dex102.htm EX-10.2 15920
4 EX-10.3 d706613dex103.htm EX-10.3 66450
5 EX-10.4 d706613dex104.htm EX-10.4 24600
  Complete submission text file 0001193125-14-131744.txt   186558
Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070
Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200
CANCER GENETICS, INC (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35817 | Film No.: 14746063
SIC: 8071 Services-Medical Laboratories